secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
CIK:        0001742927
Form:       8-K
Filed at:   2023-11-14T23:59:59+00:00
Accession:  0001437749-23-031981
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Reviva shareholders elect all five director nominees and ratify Moss Adams as auditor at 2023 annual meeting
--------------------------------------------------------------------------------

- All five director nominees elected: Laxminarayan Bhat, Parag Saxena, Richard Margolin, Purav Patel, Les Funtleyder.
- Votes for director nominees ranged from 7,991,179 to 8,713,962; broker non-votes of 5,873,081 on each.
- Ratification of Moss Adams LLP as auditor approved: 14,574,768 for, 11,880 against, 9,917 abstentions.
- Meeting held November 13, 2023; results filed under Item 5.07.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1742927/000143774923031981/0001437749-23-031981-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1742927/000143774923031981/rvph20231109_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-031981

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer